Skip to content

Additional Effect of Coherent Breathing With Aerobic Exercise on Cardiopulmonary Parameters and Quality of Life in Stage 1 Hypertensive Individuals

Additional Effect of Coherent Breathing With Aerobic Exercise on Cardiopulmonary Parameters and Quality of Life in Stage 1 Hypertensive Individuals

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07573683
Enrollment
40
Registered
2026-05-07
Start date
2026-02-28
Completion date
2026-05-15
Last updated
2026-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stage 1 Hypertensives

Keywords

Stage 1 Hypertensives, Breathing, Aerobic Exercises, Cardiopulmonary parameters, Coherent breathing technique, Quality of life

Brief summary

This study will use a randomized controlled trial to evaluate the added effects of coherent breathing combined with aerobic exercise versus aerobic exercise alone in 40 adults aged 30-65 with stage 1 hypertension. Participants will be randomly assigned to an intervention group (aerobic exercise plus coherent breathing) or a control group (aerobic exercise only) and will undergo a 4-week program with 5 sessions per week. Cardiopulmonary parameters-including blood pressure, heart rate, respiratory rate, and rate pressure product-will be measured, and quality of life will be assessed using the MINICHAL questionnaire at baseline, 2 weeks, and post-intervention. Data will be analyzed using SPSS version 21.0. The study aims to determine whether coherent breathing provides additional benefits, offering a cost-effective, non-pharmacological strategy for hypertension management in low-resource settings.

Detailed description

Hypertension, also known as high or raised blood pressure, is a condition in which the blood vessels have persistently raised pressure. A normal reading is less than 120 millimeters of mercury over less than 80 millimeters of mercury. Hypertension is a prevalent condition affecting approximately 1.28 billion individuals globally, with a significant burden observed in low- and middle-income countries such as Pakistan. Stage 1 hypertension is defined by a systolic blood pressure (SBP) between 130-139 mmHg or diastolic blood pressure (DBP) between 80-89 mmHg. High blood pressure causes no signs or symptoms, which is why healthcare providers call it a "silent killer." Non-pharmacological interventions, including aerobic exercise and breathing techniques, have shown promise in improving cardiopulmonary function and quality of life. Coherent breathing is a controlled breathing technique that involves inhaling and exhaling at a steady, slow pace-typically around five to six breaths per minute, with each inhale and exhale lasting about six seconds. This study aims to evaluate the additional effects of coherent breathing techniques when combined with aerobic exercise, compared to aerobic exercise alone. A randomized controlled trial design will be employed. The study will be conducted over a period of 1 year at Foundation University College of Physical Therapy and Fauji Foundation Hospital Rawalpindi. Ethical approval will be obtained from ERC FUMC and IRC, and the trial will be registered with CBRC and the clinical trial registry. Data will be analyzed using SPSS version 21.0. This study will fill a critical gap in the literature by assessing the additive benefits of coherent breathing in hypertension management. The findings may support cost-effective, non-pharmacological strategies in low-resource settings, contributing to improved public health outcomes

Interventions

OTHERCoherent Breathing.

Coherent breathing technique involve consciously reducing the breathing rate, typically to fewer than 10 breaths per minute, often around 6 breaths per minute. Coherent breathing is performed for 10 minutes. Aerobic Exercises involving brisk walking, warm up, stepper, static cycling, cool down for a period of 30 min.

OTHERAerobic Exercises

Aerobic Exercises involving brisk walking, warm up, stepper, static cycling, cool down for a periof of 30 min.

Sponsors

Foundation University Islamabad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This is a randomized controlled studies involving two groups. Control group will perform only aerobic exercises. Interventional group will perform both coherent breathing and aerobic exercises.

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Both male and female genders. * Adults aged 30-65 years. * Patients diagnosed with stage 1 hypertension 130-139/80-89mm Hg according to ACC/AHA 2017 guidelines. * Mild to moderate physical activity level on IPAQ questionnaire. * Individuals able to understand and follow the instructions.

Exclusion criteria

* Diagnosed uncontrolled hypertensive patients. * Unstable angina, MI, heart failure, advanced CAD patients, COPD, Asthma. * Severe neurological, musculoskeletal or gynecological conditions which limit participation in the study. * Recent history of fracture.

Design outcomes

Primary

MeasureTime frameDescription
Heart Rate (beats per minute)04 weeksMeasured using calibrated digital monitor after 5 minutes rest at baseline and post-intervention.
Systolic Blood Pressure (mmHg)04 weeksMeasured using standardized sphygmomanometer at baseline and post-intervention.
Diastolic Blood Pressure (mmHg)04 weeksMeasured using standardized sphygmomanometer at baseline and post-intervention.
Peripheral Oxygen Saturation (SpO₂, %)04 weeksMeasured using pulse oximeter under resting conditions at baseline and post-intervention.
Respiratory Rate (breaths/minute)04 weeksMeasured by direct observation at baseline and post-intervention.
Rate Pressure Product (HR × SBP)04 weeksCalculated from heart rate and systolic blood pressure at baseline and post-intervention as an index of myocardial workload.

Countries

Pakistan

Contacts

CONTACTKainat Zahra, MSPT-CPPT
zahrakainat99@gmail.com03367343005
CONTACTSyeda Sumaira Batool, MSPT-CPT
sumaira.batool@fui.edu.pk03328868680

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 8, 2026